Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)

NCT00000517 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00000517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00000517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Lead sponsor
Massachusetts General Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 31, 1985
Completion date
June 30, 1991
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, atrial fibrillation, cardiovascular diseases, cerebral embolism and thrombosis, cerebrovascular accident, cerebrovascular disorders, heart diseases, thrombophlebitis